eBook: Including China in Drug Development Programs:

Opportunities & Challenges

China represents about 20% of the world's population and, after the U.S., it has the second-largest economy. The market size alone makes it an attractive target for biopharmaceutical development, but demographic and economic changes make it even more so.

Although doing business in China presents many challenges for setting up clinical trials and performing biopharmaceutical development, most experts estimate pharmaceutical market growth there at 20% to 25% over the next decade. With a population exceeding 1.3 billion people, a large middle class and an aging population, China offers huge market potential for the biopharmaceutical industry.

Table of Contents

  • Market Opportunity
  • Regulatory Landscape
  • Including China in a Drug Development Program
  • Partnering With a CRO in China
  • On-the-Ground Challenges
  • China in 2020 and Beyond

By providing deep dives on timely industry issues, Fierce eBooks are valuable educational tools. They are designed to be easily read online — but also are formatted so you can print them out and take them with you. Fierce ebooks are assembled like a magazine, read the whole thing cover-to-cover, or pick and choose the articles that interest you most. Either way, they’re a great one-stop resource.

Complete the form to the right to download your copy today!

 

 

Sponsored By: